Overview

Bioequivalence Study of Entacapone,Levodopa and Carbidopa Tablets in the Postprandial State in Healthy Chinese Subjects

Status:
Not yet recruiting

Trial end date:
2024-11-20

Target enrollment:

Participant gender:

Summary

In this trial, 36 healthy subjects are planned to be enrolled in postprandial, and the postprandial trials will be randomized separately. According to the randomization table, subjects will be randomly assigned to one of the two groups (Group A: TRTR, Group B: RTRT). The washout period (dosing interval) between doses will be at least 2 days. Taking the washout period of 2 days as an example, all subjects will take the corresponding medication according to the randomization table on day 1 of the first cycle trial, day 3 of the second cycle trial, day 5 of the third cycle trial, and day 7 of the fourth cycle trial.

Phase:

Phase 1

Details

Lead Sponsor:

The Affiliated Hospital of Qingdao University

Treatments:

Carbidopa
Entacapone
Levodopa